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Lipidic alkynylcarbinols (LACs) have been identified as potential antitumor compounds, and a 
thorough understanding of their pharmacophoric environment is now required to elucidate their 
biological mode of action. In the dialkynylcarbinol (DAC) series, a specific study of the 
pharmacophore potential has been undertaken by focusing on the synthesis of three fluorinated 
derivatives followed by their biological evaluation. This work highlights the requirement of an 
electron-rich secondary carbinol center as a key structure for cytotoxicity in HCT116 cells. 
________________________________________________________________________________ 
Introduction 
Originally identified as natural bioactive 
compounds extracted from marine sponges or 
plant roots [1], lipidic alkynylcarbinols (LACs) 
constitute a class of potential antitumoral 
compounds [2]. Over the past few years, efforts 
have been devoted to the delineation of both 
optimal structural features [3] and cellular targets 
[4] of LAC derivatives exhibiting in vitro anti-
proliferative activity against the HCT116 colon 
tumor cell line. Noteworthy is a significant and 
systematic chirality effect, i.e. a dependence of 
the cytotoxicity on the absolute configuration of 
the LAC carbinol center. The IC50 value of a 
racemic LAC sample is thus expected to be 
roughly two times higher than that of the 
corresponding eutomer: results in the racemic 
series are however relevant prior to optimization 
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Figure 1. Insight into structure-activity relationships for 
the cytotoxicity of DACs through systematic 
pharmacophore modulation. 
 
in the eutomeric series. In the search for the 
highest potency among various LAC 
pharmacophore models [3b], the 
dialkynylcarbinol (DAC) 1 was selected as a 
reference for its high bioactivity (IC50 = 150 nM), 
structural simplicity and ready synthetic 
accessibility (Figure 1) [5]. The impact on 
cytotoxicity of further alterations of the DAC 
warhead and lipidic environment of 1 was then 
explored (Figure 1). We reported that the 
acetylated analogue (S)-2 displayed a 
cytotoxicity in HCT116 similar to that of (S)-1, 
probably due to in cellulo hydrolysis of the 
acetate moiety, releasing the free DAC [5]. In 
contrast, the O-methylated derivative 3 proved to 
be inactive (IC50 > 10 µM) [6]. This dramatic 
effect of a slight modification (H → Me) could 
be attributed to the stability of the methyl ether 
group in biological medium, persistently 
masking the alcohol moiety. Furthermore, the C-
methylated tertiary alcohol 4 displayed the same 
lack of activity. Overall, the results for 3 and 4 
may thus reflect the carbinol inability to be 
oxidized, which may be important for its 
cytotoxicity. Further investigations were thus 
envisaged through the impoverishment of the 
DAC warhead by fluorination, the targeted 
fluorinated analogues being expected to provide 
a new panel to the systematic study of the DAC 
pharmacophore.  
 
Results and discussion 
The racemic bis-propargylic fluoride 5, 
deoxyfluorinated analogue of 1, was readily 
obtained by direct treatment of 1 with 
diethylaminosulfur trifluoride (DAST, Scheme 
1) [7].  
 
Scheme 1. Synthesis of the deoxyfluorinated analogue 5 of 
the reference DAC 1. 
 
While full conversion of the alcohol was 
observed by TLC monitoring, 5 was isolated in 
low yield. This outcome can be attributed to the 
particularly high volatility of the hydrocarbon 
fluoride 5, impeding efficient purification steps 
and drying procedures. The trifluoro analogue 6 
of the tertiary alcohol 4 was secured by addition 
of ethynylmagnesium bromide onto the 
trifluoromethylated ynone 10 (Scheme 2) [8], 
itself obtained by reaction of a single equivalent 
of tetradecynyllithium on commercial ethyl 
trifluoroacetate in the presence of a 
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stoichiometric amount of boron trifluoride 
etherate [9]. 
 
Scheme 2. Synthesis of trifluoromethylated tertiary 
dialkynylcarbinol 6. 
 
The difluorinated analogue 7 with a CF2 group in 
place of the propargylic methylene group of 1 
was obtained through a concise three-step 
sequence (Scheme 3). 3,3-Difluorotetradec-1-
yne 12 was prepared by DAST-mediated 
deoxofluorination of the corresponding ynone 11 
[10], and its lithium salt was in turn added to 
TMS-propynal to give 13 with 72% yield 
(Scheme 3). Desilylation was not observed even 
under fluorination conditions with an over-
stoichiometric amount of DAST.  
 
Scheme 3. Synthesis of the difluorinated dialkynylcarbinol 
7. 
 
Removal of the TMS group, first attempted under 
standard basic conditions (K2CO3/MeOH), led to 
the formation of an unexpected compound. The 
latter was identified as the product resulting from 
the conjugate addition of three molecules of 
MeOH onto the Michael acceptor formed by a 
base-induced isomerization of the difluorinated 
alkynylcarbinol 7 [11]. This structural 
assignment was notably based on several key 
data from mass spectrometry (m/z = 380), 1H 
NMR (3 OCH3 signals at 3.49, 3.40 and 3.39 
ppm, absence of the characteristic terminal 
acetylenic proton) and 13C NMR (C=O signal at 
205 ppm). Even though several isomers of this 
structure may be formed, under basic conditions, 
the structure 14 appears the most likely (Scheme 
4).  
 
Scheme 4. Base-induced isomerization of 7 and 
subsequent transformation into the triple Michael adduct 
14 upon desilylation of 13. 
 
The final desilylation was smoothly 
accomplished using AgNO3 (Scheme 3). The 
highly sensitive difluoro-DAC 7 was isolated 
with 15% yield after column chromatography. It 
gave characterization data in full agreement with 
the expected structure. 
The antitumoral potential of the fluorinated DAC 
analogues 5-7 was then assessed by in vitro cell 
viability assays in cancer cells (Table 1). The 
HCT116 cell line was selected as a model. This 
representative human colon carcinoma cell line is 
frequently used in the biological evaluation of 
potential antitumor compounds. In addition, 
O
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cytotoxicity data against HCT116 allow direct 
comparison with our previous work [2], [3], [4]. 
 
Table 1. Cytotoxic activity of DAC analogues in HCT 116 
cancer cells. 
DAC 
derivatives IC50 [M] 
DAC 
derivatives IC50 [M] 
rac-1 0.15a,2a  rac-5 >10a 
(S)-2 0.10a,5  rac-6 >10a 
rac-3 >10a,6  rac-7 >10a 
rac-4 >50b,6    
aCells were seeded in 96-well plates and were treated with concentrations 
ranging from 10 nM to 10 M; after 48 or 72 h, the number of live cells 
was evaluated by a standard MTT test. bCells were seeded in 96-well 
plates and were treated with concentrations ranging from 10 nM to 50 
M; after 96 h, the number of live cells was evaluated by a WST test.  
 
None of the fluorinated electron-impoverished 
DAC analogues 5, 6 and 7 displayed any 
detectable activity at concentrations up to 10 μM 
(Table 1). These results indicate a correlation 
between the oxidability of DACs or analogues 
and their cytotoxicity (see Introduction and 
Figure 1): deoxyfluorination or proximal 
fluorination of the carbinol center of 1 indeed 
induces an increase of the oxidation potential in 
5-7. These results point to the requirement of an 
electron-rich carbinol center for inducing 
cytotoxicity against HCT116 cells. 
 
 
Conclusions 
The disclosed results highlight key 
features for cytotoxicity of DAC 
pharmacophores, i.e. the actual presence, 
secondary character and electron-richness of the 
carbinol center. Although the corresponding 
dialkynylketone was described as non-cytotoxic 
[6], the essential need for a readily oxidizable 
carbinol pharmacophore provides a guideline for 
the design of DACs with improved cytotoxicity. 
While a prominent criterion for cytotoxic drug 
candidates is their selectivity towards tumor cells 
vs. normal cells, the very first criterion is their 
intrinsic activity. The disclosed fluorinated 
LACs being basically not cytotoxic, they serve as 
"negative guidelines" for the design of non-
fluorinated candidates, for which this concern 
will be addressed in due course after 
optimization.  
 
Experimental part 
General. 
All reagents were obtained from commercial 
suppliers and used without any further 
purification. Dichloromethane and 
tetrahydrofuran (THF) were obtained by 
filtration through a drying column on a filtration 
system. Thin-layer chromatography (TLC) 
analyses were performed on silica gel precoated 
plates (Merck 60 F254). Visualization of the 
developed chromatogram was performed by UV 
light (254 nm) and using 10 % phosphomolybdic 
acid in EtOH, or aqueous potassium 
permanganate (KMnO4) stain. Flash column 
chromatography purifications were performed 
using flash silica gel (SDS 35-70 mm). Nuclear 
magnetic resonance spectra were recorded in 
CDCl3 on a Bruker Advance 300 MHz 
spectrometer. Chemical shifts for 1H NMR 
spectra are recorded in parts per million (ppm) 
with the solvent resonance as the reference 
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CDCl3 (δ = 7.26 ppm). Data are reported as 
follows: chemical shift, multiplicity (s = singlet, 
d = doublet, t = triplet, q = quartet, m = multiplet 
and br = broad), coupling constant in Hz and 
integration. Chemical shifts for 13C NMR spectra 
are recorded in parts per million using the central 
peak of CDCl3 (δ = 77.16 ppm) as the reference. 
All 13C NMR spectra were obtained with 
complete proton decoupling. Chemical shifts for 
19F NMR spectra are recorded in parts per million 
(ppm) with an internal standard resonance as the 
reference fluorobenzene (δ = -113.15 ppm). IR 
analysis were run on a Thermo-Nicolet Diamond 
ATR (4 cm–1 of resolution, 16 scans) equipped 
with a DTGS detector. High-resolution mass 
spectrometry (HRMS) was performed on a 
Thermo-Finnigan MAT 95 XL instrument.  
Experimental procedures and characterizations. 
3-fluorohexadeca-1,4-diyne (5). DAST (0.1 
mL, 0.8 mmol, 2.0 equiv.) was added to a 
solution of previously described [5] heptadeca-
1,4-diyn-3-ol (100 mg, 0.4 mmol) in CH2Cl2 (27 
mL) at -10 °C. The reaction mixture was warmed 
up to rt and was stirred overnight. Pentane and 
water (1:1) were added. The aqueous phase was 
extracted with pentane and the organic layer was 
separated. The combined organic layers were 
dried over MgSO4 and concentrated under 
reduced pressure. The crude product was 
submitted to flash chromatography over silica gel 
(up to pentane/Et2O, 9 : 1) to give compound 5 
(20 mg, 20%) as a colorless oil: Rf = 0.61 (100% 
pentane). 1H NMR (300 MHz, CDCl3) δ 5.68 
(dq, J = 46.9, 2.1 Hz, 1H), 2.74 (dd, J = 5.3, 2.3 
Hz, 1H), 2.27 (qd, J = 7.0, 2.1 Hz, 2H), 1.6-1.45 
(m, 2H), 1.42-1.22 (m, 18H), 0.95-0.80 (m, 3H). 
13C NMR (75 MHz, CDCl3) δ 86.3, 83.3 (d, J = 
252.0 Hz), 77.1, 72.3, 68.2, 52.3, 29.7, 29.6, 
29.2, 29.0, 28.9, 28.6, 28.4, 18.8, 18.5. 19F NMR 
(282 MHz, CDCl3) δ -160.4 (m). MS (DCI-NH3 
neg.): m/z 249 (M-1). FTIR (cm-1) (neat): 3300, 
2922, 2853, 2319, 2242, 2135, 1467, 1313, 1154, 
999, 934.  
3-(trifluoromethyl)heptadeca-1,4-diyn-3-ol 
(6). An ethynylmagnesium bromide solution 
(1.88 mL, 1.05 equiv., 0.5 M in THF) was added 
to a solution of 1,1,1-trifluorohexadec-3-yn-2-
one 10 (260 mg, 0.90 mmol) in THF (5 mL) 
under N2 atmosphere at -78 °C. The mixture was 
stirred at rt overnight. A saturated aqueous 
NH4Cl solution was added, the aqueous layer 
was extracted with Et2O and the organic layer 
was separated. The combined organic layers 
were dried over MgSO4 and concentrated under 
reduced pressure. The crude product was 
submitted to flash chromatography over silica gel 
(up to pentane/Et2O, 8 : 2) to give 
trifluoromethylated dialkynylcarbinol 6 (108 
mg, 38% over two steps) as a brown oil: Rf = 0.5 
(pentane/Et2O, 8 : 2). 1H NMR (300 MHz, 
CDCl3) δ 2.94 (s, 1H), 2.68 (s, 1H), 2.26 (t, J = 
7.1 Hz, 2H), 1.63-1.53 (m, 2H), 1.43-1.27 (m, 
18H), 0.92 (t, J = 6.7 Hz, 3H). 13C NMR (75 
MHz, CDCl3) δ 122.0 (q, J = 285.0 Hz), 88.9, 
74.4, 72.8, 68.1, 32.1, 29.8, 29.8, 29.7, 29.6, 
29.5, 29.1, 28.9, 27.9, 22.8, 18.7. HRMS (DCI-
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CH4): calcd for C18H28F3O [M+H]+: 317.2092 
m/z, found: 317.2102 m/z. FTIR (cm-1) (neat): 
3408 (br), 3307, 2924, 2854, 2246, 2129, 1266, 
1193, 1173, 1073, 998.  
6,6-difluoroheptadeca-1,4-diyn-3-ol (7). 6,6-
Difluoro-1-(trimethylsilyl)heptadeca-1,4-diyn-
3-ol 13 (320 mg, 0.9 mmol) was stirred overnight 
with AgNO3 (168 mg, 0.99 mmol, 1.1 equiv.) in 
wet acetone (5 mL). The reaction was quenched 
with water and Et2O was added. The aqueous 
layer was extracted with Et2O (3 x 4 mL) and the 
organic layer was separated. The combined 
organic layers were dried over MgSO4 and 
concentrated under reduced pressure. The crude 
product was submitted to flash chromatography 
over SiO2 (with a gradient elution up to 
pentane/Et2O, 9 : 1) to give the desired product 7 
(38 mg, 15%) as a brown oil: Rf = 0.5 
(pentane/Et2O 9:1). 1H NMR (300 MHz, CDCl3) 
δ 5.22 – 5.16 (m, 1H), 2.62 (d, J = 2.4 Hz, 1H), 
2.31 (d, J = 8.0 Hz, 1H), 2.14 – 1.91 (m, 2H), 
1.62 – 1.45 (m, 2H), 1.28 (d, J = 12.2 Hz, 16H), 
0.88 (t, J = 6.7 Hz, 3H). 13C NMR (75 MHz, 
CDCl3) δ 114.8 (t, J = 233.4 Hz), 83.1 (t, J = 6.9 
Hz), 79.4 (t, J = 2.3 Hz), 77.8, 74.2, 51.9, 39.1 (t, 
J = 25.5 Hz), 32.1, 29.7, 29.6, 29.5, 29.4, 29.1, 
22.8, 22.7 (t, J = 3.5 Hz), 14.3. 19F NMR (282 
MHz, CDCl3) δ  -83.99 (td, J = 15.1, 3.8 Hz). 
HRMS (DCI-CH4): calcd for C17H27F2O 
[M+H]+: 285.2030 m/z, found: 285.2027 m/z. 
FTIR (cm-1) (neat): 3364 (br), 3310, 2925, 2855, 
2262, 2126, 1031. 
1,1,1-trifluorohexadec-3-yn-2-one (10). 
According to previously reported reaction 
conditions [9], to a stirred solution of 1-
tetradecyne (1.73 mL, 7.04 mmol) in THF (11 
mL) was added n-butyllithium (3.7 mL, 9.15 
mmol, 2.5 M in hexanes) dropwise at -78 °C. The 
resulting solution was stirred at the same 
temperature for 30 min, at which time a solution 
of ethyl trifluoroacetate (0.84 mL, 7.04 mmol) 
and boron trifluoride diethyl etherate (0.87 mL, 
7.04 mmol) in THF (2 mL) was introduced 
dropwise. After reaction completion (ca. 1 h), a 
saturated aqueous NH4Cl solution was added. 
The aqueous layer was separated and extracted 
with Et2O. The combined organic extracts were 
washed with brine, dried over MgSO4, filtered 
and concentrated under reduced pressure to give 
the crude product, which was purified by flash 
chromatography on silica gel (up to 
pentane/Et2O, 8 : 2) to afford desired 
trifluoromethylketone 10 (260 mg, 13%). 
Spectral data were comparable with those 
previously reported in the literature [9b] and are 
not described in detail. 
Tetradec-1-yn-3-one (11). Dess-Martin 
periodinane reagent (202 mg, 0.48 mmol, 1 
equiv.) was added to a solution of tetradec-1-yn-
3-ol (100 mg, 0.48 mmol) in CH2Cl2 (2 mL) 
under N2 atmosphere. The mixture was stirred at 
rt overnight. A saturated aqueous NaHCO3 
solution was added, the aqueous layer was 
extracted with CH2Cl2 and the organic layer was 
separated. The combined organic layers were 
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dried over MgSO4 and concentrated under 
reduced pressure. The crude product was 
submitted to flash chromatography over silica gel 
(up to pentane/Et2O, 8 : 2) to give ketone 11 (86 
mg, 87%) as a yellow oil: Rf = 0.57 
(pentane/Et2O, 8 : 2). 1H NMR (300 MHz, 
CDCl3) δ 3.19 (s, 1H), 2.58 (t, J = 7.4 Hz, 1H), 
1.67 (t, J = 7.2 Hz, 2H), 1.57 (s, 1H), 1.33-1.22 
(m, 16H), 0.95 (t, J = 6.0 Hz, 3H). 13C NMR (75 
MHz, CDCl3) δ 187.8, 81.6, 78.4, 45.6, 32.0, 
29.7, 29.5, 29.4, 29.0, 23.9, 22.8, 14.3. FTIR 
(cm-1) (neat): 3299, 3255, 2853, 2924, 2093, 
1683, 1466.  
3,3-difluorotetradec-1-yne (12). Tetradec-1-yn-
3-one 11 (1.5 g, 7.2 mmol) and DAST (2.23 mL, 
18 mmol, 2.5 equiv.) were heated neat at 56 °C 
and stirred under nitrogen atmosphere over 5 h. 
The crude product was submitted to flash 
chromatography over silica gel (up to pentane 
/Et2O, 95 :5) to give the difluorinated product 12 
(1.0 g, 60%) as a yellow oil: Rf = 0.57 
(pentane/Et2O, 8 : 2). 1H NMR (300 MHz, CDCl3) 
δ 2.74 (t, J = 4.9 Hz, 1H), 2.10-1.94 (m, 2H), 1.60-
1.50 (m, 2H), 1.39-1.22 (m, 16H), 0.93 (t, J = 5.4 Hz, 
3H). 13C NMR (75 MHz, CDCl3) δ 114.6 (t, J = 232.0 
Hz), 75.1 (t, J = 6.8 Hz), 39.2 (t, J = 25.4 Hz), 32.1, 
29.9, 29.7, 29.6, 29.5, 29.1, 23.0, 14.3. 19F NMR (282 
MHz, CDCl3) δ -83.9 (td, J = 15.1 Hz, 5.0 Hz). FTIR 
(cm-1) (neat): 3305, 2923, 2854, 2134, 2095, 
1685, 1466. 
6,6-difluoro-1-(trimethylsilyl)heptadeca-1,4-
diyn-3-ol (13). n-Butyllithium solution (2.6 mL, 
0.65 mmol, 1.2 equiv., 2.5 M in hexanes) was 
added to a solution of 3,3-difluorotetradec-1-yne 
12 (125 mg, 0.54 mmol) in THF (15 mL) under 
N2 atmosphere at -78 °C. After 45 min of stirring, 
3-(trimethylsilyl) propiolaldehyde (0.1 mL, 3.17 
mmol, 5.8 equiv.) was added at -78 °C. 
Temperature and stirring were maintained during 
30 min. A saturated aqueous NH4Cl solution was 
added, the aqueous layer was extracted with Et2O 
and the organic layer was separated. The 
combined organic layers were dried over MgSO4 
and concentrated under reduced pressure. The 
crude product was submitted to flash 
chromatography over silica gel (up to 
pentane/Et2O, 9 : 1) to give dialkynylcarbinol 13 
(140 mg, 72%) as a brown oil: Rf = 0.47 
(pentane/Et2O, 9 : 1). 1H NMR (300 MHz, 
CDCl3) δ 5.17 (dt, J = 7.5, 3.7 Hz, 1 H), 2.26 (d, 
J = 7.3 Hz, 1H), 2.12-1.96 (m, 2H), 1.60-1.49 (m, 
2H), 1.37-1.22 (m, 16H), 0.94 (t, J = 13.4 Hz, 
3H), 0.20 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 
127.2, 117.8, 114.7, 111.6, 100.0, 91.2, 83.5 (t, J 
= 7.0 Hz), 77.3, 52.3, 39.1 (t, J = 25.5 Hz), 31.9, 
29.6, 29.5, 29.4, 29.0, 23.3, 14.1, 0.0. 19F NMR 
(282 MHz, CDCl3) δ -83.79 (td, J = 15.0 Hz, 3.6 
Hz). FTIR (cm-1) (neat): 3390 (br), 2926, 2856, 
1467, 1252, 1043, 845, 761. 
6,6-difluoro-1,1,5-trimethoxyheptadecan-3-
one (14): 6,6-Difluoro-1-
(trimethylsilyl)heptadeca-1,4-diyn-3-ol 13 (140 
mg, 409 µmol) was stirred overnight with K2CO3 
(169 mg, 1.2 mmol, 3 equiv.) and MeOH (2 mL). 
A saturated aqueous NH4Cl solution was added, 
the aqueous layer was extracted with Et2O (3 x 5 
mL) and the organic layer was separated. The 
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combined organic layers were dried over MgSO4 
and concentrated under reduced pressure. The 
crude product was submitted to flash 
chromatography over SiO2 (up to pentane/Et2O, 
9 : 1) to give the triple Michael adduct 14 (50 mg, 
33%) as a brown oil: Rf = 0.5 (pentane/Et2O 9:1). 
1H NMR (300 MHz, CDCl3) δ 4.84 (t, J = 5.6 
Hz, 1H), 4.05 –3.92 (m, 1H), 3.49 (s, 3H), 3.40 
(s, 3H), 3.39 (s, 3H), 2.81 (dd, J = 5.6, 2.0 Hz, 
2H), 2.76 (d, J = 5.8 Hz, 2H), 2.07 – 1.72 (m, 
2H), 1.59 – 1.47 (m, 2H), 1.33-1.19 (m, 16H), 
0.97 (t, J = 6.7 Hz, 3H). 13C NMR (75 MHz, 
CDCl3) δ 204.5 (C=O), 125.7 (t, J = 245.9 Hz, 
CF2), 101.4, 77.4 (dd, J = 30.4, 27.8 Hz), 60.0 
(OMe), 54.2 (OMe), 53.8 (OMe), 47.4, 43.7 (dd, 
J = 3.8, 1.9 Hz), 32.7 (t, J = 24.1 Hz), 32.0, 29.7, 
29.6, 29.6, 29.5, 29.5, 22.8, 21.4 (t, J = 4.3 Hz), 
14.3. MS (DCI-NH3 neg.): m/z 280 (M-1).  
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